Inventor
CHEN XIANGYANG
CN32 patents
⚠️ This page may combine multiple inventors who share the name “CHEN XIANGYANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEIJING INNOCARE PHARMA TECH CO LTD
13 patentsUS9951056B2Apr 24, 2018
Substituted nicotinamide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
BEIJING INNOCARE PHARMA TECH CO LTD5 citations81
US11572353B2Feb 7, 2023
Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof
BEIJING INNOCARE PHARMA TECH CO LTD2 citations70
US12297188B2May 13, 2025
Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide
BEIJING INNOCARE PHARMA TECH CO LTD0 citations62
US11059805B2Jul 13, 2021
Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof
BEIJING INNOCARE PHARMA TECH CO LTD0 citations59
US12391666B2Aug 19, 2025
Indoline-1-formamide compound, preparation method therefor, and medical use thereof
BEIJING INNOCARE PHARMA TECH CO LTD0 citations58
US11578058B2Feb 14, 2023
Heterocyclic compounds for inhibiting TYK2 activities
BEIJING INNOCARE PHARMA TECH CO LTD0 citations58
US11389445B2Jul 19, 2022
Pentafluorosulfanyl-substituted amide derivatives, preparation methods thereof and medical uses thereof
BEIJING INNOCARE PHARMA TECH CO LTD0 citations58
US12178808B2Dec 31, 2024
Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
BEIJING INNOCARE PHARMA TECH CO LTD0 citations54
US11945792B2Apr 2, 2024
Crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
BEIJING INNOCARE PHARMA TECH CO LTD0 citations54
US12202813B2Jan 21, 2025
Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
BEIJING INNOCARE PHARMA TECH CO LTD0 citations51
US11046682B2Jun 29, 2021
Fused heterocyclic derivatives, their preparation methods thereof and medical uses thereof
BEIJING INNOCARE PHARMA TECH CO LTD0 citations50
US10710981B2Jul 14, 2020
Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof
BEIJING INNOCARE PHARMA TECH CO LTD0 citations49
US10336755B2Jul 2, 2019
Fused pyrazole derivatives, preparation method thereof, and use thereof in treatment of cancers, inflammation and immune diseases
BEIJING INNOCARE PHARMA TECH CO LTD0 citations37
GUANGZHOU INNOCARE PHARMA TECH CO LTD
6 patentsUS10301297B2May 28, 2019
Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
GUANGZHOU INNOCARE PHARMA TECH CO LTD3 citations69
US12162873B2Dec 10, 2024
Substituted nicotinimide inhibitors of BTK for treating cancer
GUANGZHOU INNOCARE PHARMA TECH CO LTD0 citations60
US11840513B2Dec 12, 2023
Substituted nicotinimide inhibitors of BTK for treating cancer
GUANGZHOU INNOCARE PHARMA TECH CO LTD0 citations60
US11345695B2May 31, 2022
Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
GUANGZHOU INNOCARE PHARMA TECH CO LTD0 citations59
US12448382B2Oct 21, 2025
Heterocyclic compounds for mediating tyrosine kinase 2 activity
GUANGZHOU INNOCARE PHARMA TECH CO LTD0 citations47
US10752631B2Aug 25, 2020
Heterocyclic compounds as FGFR inhibitors
GUANGZHOU INNOCARE PHARMA TECH CO LTD0 citations39